Literature DB >> 32989588

Long-term persistence of NMDAR antibodies after encephalitis with de novo occurrence of demyelinating disorder.

Maria Tappatà1, Patrizia Riguzzi2, Lilia Volpi2, Luca Albini Riccioli3, Roberta Pantieri2, Roberto Michelucci2.   

Abstract

The issue of persistence of NMDAR antibodies after encephalitis is not fully elucidated and their relationship with demyelinating disorders has been suggested. A female patient showed at the age of 18 an acute neurological disorder (with psychiatric symptoms, focal seizures, orofacial dyskinesias and hypoventilation requiring ventilatory support) clinically mimicking anti-NMDAR encephalitis. At that time specific laboratory tests were not available, CSF revealed oligoclonal bands and MRI was negative. The patient had full recovery after first line immunotherapy (i.v. steroids and immunoglobulins). Fifteen years later, at the age of 33, she was hospitalized with subacute right hemiparesis and MRI disclosed multiple T2 hyperintensities in the white matter, one of them in the left midbrain showing contrast enhancement. Serum and CSF NMDAR antibodies were positive while MOG and AQP4 antibodies were negative. Intravenous methylprednisolone led to complete recovery. This case report provides evidence of a long-term persistence of NMDAR antibodies even 15 years after the encephalitis and raises the suspicion of a possible causal relationship between NMDAR antibodies and demyelinating disorders in the form of multiple sclerosis.

Entities:  

Keywords:  Clinical course; Encephalitis; NMDAR antibodies

Mesh:

Substances:

Year:  2020        PMID: 32989588     DOI: 10.1007/s10072-020-04729-3

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  2 in total

1.  Antecedent anti-NMDA receptor encephalitis in two patients with multiple sclerosis.

Authors:  A Baheerathan; W J Brownlee; D T Chard; K Shields; R Gregory; S A Trip
Journal:  Mult Scler Relat Disord       Date:  2016-12-29       Impact factor: 4.339

Review 2.  Anti-NMDAR encephalitis followed by seropositive neuromyelitis optica spectrum disorder: A case report and literature review.

Authors:  Ye Ran; Lu Wang; Fangfang Zhang; Ran Ao; Zhao Dong; Shengyuan Yu
Journal:  Clin Neurol Neurosurg       Date:  2017-02-27       Impact factor: 1.876

  2 in total
  1 in total

Review 1.  Clinical Characteristics of Anti-N-Methyl-d-Aspartate Receptor Encephalitis Overlapping with Demyelinating Diseases: A Review.

Authors:  Shujiang Zhang; Yuan Yang; Wenyu Liu; Zuoxiao Li; Jinmei Li; Dong Zhou
Journal:  Front Immunol       Date:  2022-06-28       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.